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he granting of clinical staff privileges to physicians is a
rimary mechanism used by institutions to uphold the
uality of care. The Joint Commission on Accreditation of
ealthcare Organizations requires that the granting of
ontinuing medical staff privileges be based on assessments
f applicants against professional criteria specified in the
edical staff bylaws. Physicians themselves are thus charged
ith identifying the criteria that constitute professional
ompetence and with evaluating their peers accordingly.
et, the process of evaluating physicians’ knowledge and
ompetence is often constrained by the evaluator’s own
nowledge and ability to elicit the appropriate information,
roblems compounded by the growing number of highly
pecialized procedures for which privileges are requested.
The American College of Cardiology Foundation
ACCF)/American Heart Association (AHA)/American
ollege of Physicians (ACP) Task Force on Clinical Com-
etence and Training was formed in 1998 to develop
ecommendations for attaining and maintaining the cogni-
ive and technical skills necessary for the competent perfor-
ance of a specific cardiovascular service, procedure, or
echnology. These documents are evidence-based, and
here evidence is not available, expert opinion is utilized to
ormulate recommendations. Indications and contraindica-he scope of these documents. Recommendations are in-
ended to assist those who must judge the competence of
ardiovascular health care providers entering practice for the
rst time and/or those who are in practice and are under-
oing periodic review of their practice expertise. The assess-
ent of competence is complex and multidimensional;
herefore, isolated recommendations contained herein may
ot necessarily be sufficient or appropriate for judging
verall competence. The current document addresses com-
etence in vascular imaging for computed tomography (CT)
nd magnetic resonance (MR) and is authored by represen-
atives of the ACCF, the AHA, the Society of Atheroscle-
osis Imaging and Prevention (SAIP), the Society for
ardiovascular Angiography and Interventions (SCAI), the
ociety of Cardiovascular Computed Tomography
SCCT), the Society for Cardiovascular Magnetic Reso-
ance (SCMR), and the Society for Vascular Medicine and
iology (SVMB).
The ACCF/AHA/ACP Task Force makes every effort to
void any actual or potential conflicts of interest that might
rise as a result of an outside relationship or a personal
nterest of a member of the ACCF/AHA/ACP Writing
ommittee. Specifically, all members of the Writing Com-
ittee are asked to provide disclosure statements of all such
elationships that might be perceived as real or potential
onflicts of interest relevant to the document topic. These
re reviewed by the Writing Committee and updated as
hanges occur. The relationships with industry information
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ices of the document.
Mark A. Creager, MD, FACC, FAHA
Chair, ACCF/AHA/ACP Task Force on
Clinical Competence and Training
ntroduction
his statement is the first American College of Cardiology
ACC)/AHA document on clinical competence in vascular
omputed tomography (CT) and magnetic resonance im-
ging (MRI) and is designed to assist in the assessment of
hysicians’ competence on a procedure-specific basis. The
inimum experience, knowledge base, and technical skills
ecessary for the competent performance of vascular CT
nd MRI are specified. These represent the minimum
xperience requirements for the assessment of competence
n these disciplines (or procedures) in the broadest sense.
henever possible, the specifications are primarily based on
onsensus of expert opinion in the absence of extensive
iterature that links these factors with competence. The
pecifications are applicable to different practice settings and
raining backgrounds and can accommodate a number of
ays in which physicians can demonstrate competence in
he performance of specific procedures. Expertise in the
erformance of these procedures in patients with infre-
uently encountered diagnoses or of less commonly per-
ormed variations of standard procedures may require addi-
ional experience or training. Therefore, it is expected that
ven highly competent practitioners will occasionally benefit
rom consultation with colleagues who have even more
ighly specialized interests, experience, or skills. Due to the
uantity and complexity of nonvascular findings that may be
maged with either technique, competence in imaging and
nterpretation of these findings is beyond the scope of this
ocument.
This document addresses physicians who have already
ompleted a formal training program and is not meant to
ncompass the training requirements for performing vascu-
ar MRI and CT. The process of acquiring these skills is
able 1. CT Hardware
CT Hardware
-ray tube and focal spot Usually consists of a cathode from which
of X-rays. Some manufacturers allow d
focal spot”). Both tube current (mA) an
antry X-ray tube and detector array are mounte
gravitational forces.
ube collimator Located between X-ray tube and patient a
collimation) is adjusted according to th
etectors Comprise solid-state elements that conve
electrical signal. A fixed array detector
array has detectors of different widths
itch Equal to table feed per rotation (mm)/tot
0.2 to 0.4 is required, while higher pitcT  computed tomography; ECG  electrocardiogram.ifferent once one has completed a formal training program.
raining guidelines will be covered in the latest edition of
ore Cardiology Training (COCATS) for cardiology train-
es and in other documents put forth by other societies (1).
In addition to members of the ACCF and the AHA,
he Writing Committee included representatives of the
AIP, the SCAI, the SCCT, the SCMR, and the
VMB. Representation by an outside organization does
ot necessarily imply endorsement. In addition to con-
ent peer reviewers, “official” reviewers were provided by
he ACC and the AHA. This document was approved for
ublication by the governing bodies of the ACC and the
HA. In addition, the governing boards from the SAIP,
he SCAI, the SCCT, the SCMR, and the SVMB
ormally endorsed this document.
ascular CT
ognitive Knowledge Required for Competency
. Hardware
hysicians interested in computed tomographic angiogra-
hy (CTA) should have knowledge of advances in CT
ardware (Table 1) which have accelerated since the intro-
uction of axial CT in 1973. Starting with a rotating gantry
ncorporating an X-ray source, there have been progressive
ncreases in the number of detector elements (2). Advances
ver the last decade include table translation simultaneous
ith rotation of a gantry incorporating an X-ray source with
xtended longitudinal or z-axis coverage. Thus, images can
e reconstructed at any position along the patient axis
longitudinal or z-axis), and overlapping image reconstruc-
ion is used to improve longitudinal resolution (3). The
ntroduction of 16-slice CT in 2003 marked the arrival of
echnology to assess all vascular territories including the
ower extremities using detectors that were 0.75 mm or less
n width. The 64-slice CT systems introduced in 2004 have
esulted in further reductions in gantry rotation times to 330
o 420 ms and improved performance of electrocardio-
raphic (ECG)-referenced scanning. Dual-source CT scan-
Details
ons are emitted onto a spot on the anode (focal-spot) resulting in a generation
ic deflection of the electron beam striking the anode along the z-axis (“flying
age (kVp) are adjustable parameters.
osite each other on a rotating gantry capable of withstanding high
used to shape the beam along the longitudinal (z) axis. The opening (beam
cted slice width and the size/position of focal spot.
y into light impulses, and photodiodes, which convert the light into an
sts of detector elements with equal sizes in the z direction, while an adaptive
th of the collimated beam. For ECG-referenced vascular applications, a pitch of
reater than 1.0) may suffice for nongated vascular applications.electr
ynam
d volt
d opp
nd is
e sele
rt X-ra
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.
al wid
hes (g
n
r
o
c
t
s
b
a
c
d
a
t
T
t
r
i
s
s
t
i
2
P
r
e
t
s
r
a
p
c
s
a
t
P
s
a
a
t
a
C
q
p
e
3
M
E
p
p
c
m
a
(
p
v
t
u
d
t
a
i
e
(
A
a
s
o
a
t
t
g
v
C
t
n
a
a
4
A
t
i
c
P
t
c
s
m
a
t
a
m
b
m
m
l
t
u
p
s
t
5
A
o
C
e
p
u
1100 Kramer et al. JACC Vol. 50, No. 11, 2007
ACCF/AHA Clinical Competence Statement: Vascular CT/MR September 11, 2007:1097–114ers introduced in 2006 further improve the temporal
esolution of the ECG-referenced acquisition. A brief
verview of the technical aspects of an multi-detector row
omputed tomography (MDCT) technology is included
o facilitate understanding of the terms used in the
ubsequent sections of this report but is not intended to
e comprehensive.
The MDCT design has evolved through successive iter-
tions. In its simplest form, a modern MDCT scanner
omprises an X-ray source, rotating gantry, pre- and post-
etector collimators, and detector arrays. The detector
ssembly comprises several rows of detector elements that
ypically cover a scan field of view of approximately 50 cm.
he attenuation data (after passing from the source,
hrough the body, and incident on the detector array) are
ecorded and transformed through filtered back-projection
nto the CT image. Axial or sequential scanning is the
implest and oldest technique for acquiring data. Helical/
piral scanning is characterized by continuous gantry rota-
ion and continuous data acquisition while the patient table
s moving at a constant speed.
. Acquisition Techniques
hysicians must demonstrate competence in the techniques
equired in the acquisition and interpretation of a CTA
xam. Specific acquisition techniques will be determined by
he brand and capability of the scanner; a complete discus-
ion is beyond the scope of this statement. In general, the
egion of interest for which the CTA has been requested
nd the scanner capacity will determine the scan acquisition
arameters (4). Intravenous administration of an iodinated
ontrast medium must be synchronized with image acqui-
ition. The volume, duration, and injection rate of contrast
dministration will be determined by the iodine concentra-
ion of the contrast and the duration of the scan (5).
hysicians performing CTA must demonstrate an under-
tanding of the factors that determine contrast transit times
nd the available means to accurately synchronize contrast
dministration and scanning. Candidates must understand
he relative merits and limitations of both timing bolus and
utomated bolus monitoring techniques (6). Practitioners of
TA should understand the necessary adjustments in ac-
uisition techniques for imaging pediatric patients, obese
atients, patients that cannot raise their arms, and uncoop-
rative patients.
. Image Processing and Interpretation
DCT acquires hundreds to thousands of axial images (7).
valuation of the available source images is essential. The
ractitioner of CTA should also be comfortable with
ost-processing techniques which are performed at the
omputer workstation console. Arterial anatomy traverses
ultiple planes and, thus, cannot be completely displayed by
xial or any other single projection. Multiplanar reformats
MPR) present the angiogram in two-dimensional (2D)
lanes. Curved multiplanar reformats (CMPR) trace a tessel through its contour and display the described axis
hrough the vessel in a 2D plane. The CMPR is extremely
seful for lumen measurement, thereby facilitating the
etection of stenoses and measurement of aneurysms. As
he interpreter defines the anatomy, both MPR and CMPR
re subject to artifact if the true center of the vessel is
ncorrectly identified. Slab imaging allows the interpreter to
valuate the vessel lumen. Maximum intensity projection
MIP) displays the pixels with greatest Hounsfield value.
lthough MIPs may appear most similar to an invasive
ngiogram, calcification may preclude interpretation of ves-
el lumen; this format may underestimate and sometimes
verestimate stenoses. Volume rendering (VR) displays the
cquired data set as a three-dimensional (3D) reconstruc-
ion. This technique accurately displays, in a readily iden-
ifiable manner, the course of vessels and surgical bypass
rafts. It also easily demonstrates the relationship between
essels and extravascular structures. Physicians performing
TA must understand the diagnostic potential and limita-
ions of each of the aforementioned interpretative tech-
iques. They should also be able to recognize common
rtifacts including partial volume averaging or blooming
rtifacts from calcification and stents.
. Contrast Agents
side from exposure to ionizing radiation, iodinated con-
rast material is the most significant risk of CTA. Contrast-
nduced nephropathy (CIN) is the third most common
ause of acute renal failure among hospitalized patients (8).
hysicians who wish to perform CTA must recognize that
he presence of diabetes mellitus, pre-existing renal insuffi-
iency, congestive heart failure, and recent contrast exposure
ignificantly increase the risk of CIN (9–11). Practitioners
ust understand measures that may offer some protection
gainst CIN such as hydration, discontinuation of nephro-
oxic drugs, and the use of nonionic, iso-osmolar contrast
gents (12–15). Severe anaphylactic reactions to contrast
aterial are seen in 0.04% to 0.22% of procedures and can
e life threatening (16). Less severe allergic reactions are
ore commonly observed (17). Physicians performing CTA
ust be well acquainted with the treatment of cardiovascu-
ar collapse due to anaphylactic allergic reactions as well as
o less severe reactions. They also must understand how to
se prophylactic therapy prior to contrast administration in
atients with a previous history of allergic response. They
hould consider a recommendation of alternative testing in
hose with a history of significant allergic reaction.
. Radiation Dosimetry
lthough ionizing radiation from natural sources is part of
ur daily existence, it is mandatory that practitioners of
TA understand the potential risks of ionizing radiation
xposure from the test and balance these risks against the
otential benefits. Health care professionals must have an
nderstanding of the exposure involved in MDCT applica-
ions that image the vasculature and to effectively advise
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September 11, 2007:1097–114 ACCF/AHA Clinical Competence Statement: Vascular CT/MRandidates for imaging. Patient doses for MDCT acquisi-
ion should be set at the lowest values that are consistent
ith satisfactory image quality. Most physicians seeking
raining in CTA applications will likely have had some
idactic teaching regarding radiation physics during their
raining. However, specific instruction to keep radiation
xposure as low as possible when performing MDCT may
e additionally required. In general, there are differences in
adiation exposure depending on the vascular application.
doption of the effective dose as a standard measure of
iologic risk allows comparability across the spectrum of
edical and nonmedical exposures. The effective dose is, by
efinition, an estimate of the uniform, whole-body equiva-
ent dose that would produce the same level of risk of
dverse effects as from nonuniform partial body irradiation.
he unit for the effective dose is the milliSievert (mSv)
www.fda.gov/cdrh/ct/rqu.html). Typical values for the ef-
ective patient dose of selected CT protocols are 1 to 2 mSv
or a head examination, 6 to 14 mSv for noncoronary CTA
f the chest, and 8 to 16 mSv for CTA of the abdomen,
elvis, and lower extremities, depending on patient and
canner variables that may include dose-reduction strategies
18–23). The effective dose of retrospective ECG-gated
xams is much higher than that of nongated exams. This
adiation exposure must be appreciated in the context of the
verage annual background radiation, which is 2 to 5 mSv
average  3.6 mSv in the United States).
Axial/sequential techniques require less radiation and
ould be used for clinical indications that are least compro-
ised by motion artifacts. In helical/spiral MDCT, which is
ore commonly used for chest angiography, the dose can be
educed by 30% to 50% by using ECG-controlled dose-
odulation techniques. Another approach relevant to clin-
cal practice is anatomic tube current modulation where the
ube output is adapted to the patient geometry during each
otation of the scanner to compensate for strongly varying
-ray attenuations in asymmetric regions such as the
houlders and pelvis (24). The radiation dose increases with
hinner slices (because tube current is typically increased to
aintain image noise) and smaller pitch (more overlapping
mages). Another means to reduce radiation dose is to adapt
he X-ray tube voltage to the intended application. Patient
ose can be reduced by choosing lower kVp settings. A
ecent study reports a dose savings of 30% without a loss of
iagnostic information with 100 kVp when evaluating the
orta and iliac arteries (22). This approach, however, may
ot be appropriate for obese patients because penetration of
-rays decreases with decreasing tube voltage.
. Specific Applications
. AORTA
he practitioner of CTA should be knowledgeable about
he utility of conventional CT scanning for diagnosing
horacic aortic aneurysms and dissections (25,26). The
nowledge required to perform aortic CTA includes the
bility to diagnose aortic dissection, which can be identified eith greater than 95% accuracy. Excellent definition of the
ntimal flap, false and true lumens, and the amount of
ntra-aneurysmal thrombus can be determined. Practitio-
ers of CTA should understand its use for diagnosing aortic
neurysm, defining its maximal diameter, and monitoring
ts expansion over time (27). Recognition of the use of CTA
o diagnose traumatic aneurysms of the thoracic aorta, sinus
f Valsalva aneurysms, and coarctation of the aorta is
mportant. The diagnostician should understand the poten-
ial advantages of CTA in patients undergoing “redo”
oronary artery bypass surgery (28). CTA may guide the
urgical approach by defining the position of the sternum to
he right ventricle, existing grafts, and aorta and thereby
void unnecessary complications. The imager should recog-
ize that the presence of severe aortic plaque raises the risk
f stroke during “redo” surgery.
. UPPER EXTREMITY ARTERIES
here is limited clinical data on the utility and performance
f CTA for the diagnosis and management of upper
xtremity arterial disease (29,30). CTA of upper extremity
rterial disease requires knowledge of variant anatomy of the
rch vessels including aberrant origins. Subclavian artery
tenosis from a number of diseases, including atherosclerosis
nd vasculitis, can be effectively diagnosed using CTA. An
nderstanding of the role of CTA in the diagnosis and
anagement of subclavian and axillary aneurysms is essen-
ial. CTA allows accurate measurements of the diameter of
he area to be treated as well as the length of the appropriate
ndograft. CTA can also be utilized for post-intervention
urveillance to assess for endoleaks or deformity of the
evice. Recognition of the etiology and anatomic location of
he ischemic upper extremity is crucial to those who wish to
ractice CTA. Common causes include atherosclerotic dis-
ase, embolism (cardiac and vascular sources including
horacic outlet syndrome), and vasculitis. CTA can provide
mportant information on the anatomy of the thoracic
utlet; angiography with provocative maneuvers can be
elpful in establishing the diagnosis.
An understanding of the potential involvement of the
pper extremity in up to 40% of extremity-penetrating
rauma is important for CTA interpreters (31). Trauma can
lso result in vascular spasm, an intimal tear, pseudoaneu-
ysm, arteriovenous fistula, or occlusion. CTA surveillance
f hemodialysis access should be understood by those who
erform the procedure. Because there is no concern for
xacerbating renal dysfunction with iodinated contrast ad-
inistration in hemodialysis patients, CTA offers a rapid,
igh spatial resolution study to assess graft patency and
rterial inflow and venous outflow.
. EXTRACRANIAL CEREBROVASCULAR ARTERIES
ractitioners should recognize that the use of CTA is
apidly increasing for vascular evaluation in patients with
uspected cerebrovascular disease. CT is often the initial test
n patients with transient ischemic attack (TIA) or stroke to
xclude hemorrhage and to detect early changes associated
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dding only 5 to 10 min to the study and providing real
natomic detail. CTA measurements of percent stenosis
how a high correlation with digital subtraction angiography
DSA) (32) and in fact, 3D reconstructions of the carotid
ften permit a more complete assessment of eccentric
esions. An understanding that calcification interferes with
TA is crucial, particularly in complex calcified plaques
here the degree of stenosis may not be adequately assessed.
egments of the carotid parallel to the plane of imaging are
ubject to flow effects, and stenosis of these regions may be
rtifactual. Knowledge of the strengths, weaknesses, and
otential pitfalls of CTA imaging is essential to appropriate
nd accurate interpretation.
An understanding of the pathophysiological processes
hat affect the cerebral arteries is also important. Athero-
clerosis is the most common cause of arterial narrowing
nd typically occurs at the carotid bifurcation in the neck, at
he origin from the aortic arch, and in the intracranial
egment at the level of the carotid siphon (33). Practitioners
f CTA should be able to recognize other pathologies such
s dissection, intraluminal thrombus, vasculitis, or vaso-
pasm that may appear similar on CTA but should be
istinguished by the clinical setting and anatomic charac-
eristics. Knowledge of the clinical features of diseases that
ffect the cerebral circulation is necessary for optimal inter-
retation of CTA. In addition, recognition of symptoms
ttributable to the carotid and basilar circulation is impor-
ant to focus interpretation on the clinically relevant arterial
egments.
Knowledge of the different types of cerebral aneurysms is
ssential to physicians performing CTA, as CTA can
eadily define their size, length, and diameter. A thorough
nderstanding of the appearance and distribution of arterial
issection is important to the proper identification and
nterpretation of CTA. Traumatic injury to the carotid
rtery commonly results in dissection. CTA practitioners
hould know that CTA may demonstrate a small irregular
umen even when other studies such as magnetic resonance
ngiography (MRA) or carotid ultrasound suggest occlusion
34,35).
. PELVIC AND LOWER LIMB ARTERIES
t should be understood that a complete acquisition of lower
xtremity inflow and run-off is presently available with
DCT angiography that was not previously available with
ewer detectors (36). The increase in spatial resolution now
fforded by CTA allows the differentiation between high-
nd low-grade stenoses in peripheral vasculature, and the
haracterization of the nature of the lesion, differentiating
theromatous from thrombotic stenoses (37). CTA practi-
ioners should understand that it has been shown to have
xcellent correlation with DSA (38–40). Limitations of
TA include the presence of dense calcifications and
ndoluminal stents, which may impair the quantification of
he degrees of peripheral arterial disease (PAD). tPractitioners must demonstrate a thorough knowledge of
rterial pathophysiology and its clinical presentation.
nowledge of just atherosclerotic disease is not sufficient.
ompetency also requires an understanding of inflamma-
ory and aneurysmal diseases, thromboembolic disease, vas-
ular injury, spontaneous and iatrogenic dissections, and
ongenital abnormalities. The capacity of CTA to visualize
he arterial wall, as well as the lumen, provides the inter-
reter a greater degree of certainty when arriving at less
ommon diagnoses. The relationship and effect of other
natomic structures on the vasculature must be understood,
uch as compression of venous structures by pelvic tumors
esulting in stasis and thrombosis or dynamic compression
f an entrapped popliteal artery. Knowledge of the potential
tility of CTA in the evaluation of graft patency is impor-
ant as well as in the detection of graft-related complications
graft stenosis, aneurysmal changes, and arteriovenous fis-
ulas). Practitioners of CTA should recognize the value of
TA in the setting of peripheral vascular trauma in the
ssessment of complicated or partial occlusions, arterio-
enous fistulae, intimal flaps, and pseudoaneurysms (31).
. RENAL ARTERIES
he knowledge required to perform CTA of the renal
rteries includes an understanding of the normal anatomy
nd its common variations such as accessory renal branches
nd familiarity with vascular anomalies and the usual loca-
ion and appearance of a transplanted kidney (41). The
iagnostician should be cognizant of the various etiologies
f renal artery stenosis, including atherosclerosis, fibromus-
ular dysplasia, and other causes of renovascular disease such
s polyarteritis nodosa, arteriovenous fistulae, aneurysms,
hrombosis, and embolism. Identification of renal parenchy-
al enhancement patterns identifying the cortex, medulla,
nd the collecting system is important for the recognition of
ntrinsic parenchymal disease. The interpreter should be
apable of relating renal CTA findings with results of other
iagnostic imaging modalities, particularly duplex ultra-
onography and MRA.
. MESENTERIC ARTERIES
TA of the mesenteric arteries requires knowledge of the
ormal anatomy of the celiac artery, superior mesenteric
rtery, and inferior mesenteric artery as well as the common
ariants and collaterals such as pancreaticoduodenal collat-
rization and the marginal artery of Drummond, a collateral
essel to the superior mesenteric artery. The expert should
e cognizant of the etiologies and pathophysiology of
esenteric ischemia such as atherosclerosis, arterial throm-
osis or embolism, vasculitis, celiac trunk compression from
he median arcuate ligament, and mesenteric vein throm-
osis (41). The CTA specialist should recognize the clinical
anifestations of mesenteric ischemia and be knowledge-
ble about the indications for endovascular and surgical
herapies for both acute and chronic mesenteric ischemia.
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September 11, 2007:1097–114 ACCF/AHA Clinical Competence Statement: Vascular CT/MR. CT VENOGRAPHY
he practitioner of CTA should understand the use of
eripheral venous CT for demonstrating deep venous
hrombosis (DVT), especially the proximal extent into the
liac vein or inferior vena cava (IVC) (42). CT venography
rovides direct imaging of the IVC, pelvic and lower
xtremity veins immediately after CT of the pulmonary
rteries without injection of additional contrast material,
dding only a few minutes to the examination. The diag-
ostician should be aware that because DVT is the most
mportant factor predisposing to pulmonary embolism (PE),
single examination capable of evaluating both the pulmo-
ary arterial system and the pelvic and lower extremity
enous system may offer advantages over other tests directed
t either diagnosis alone (43). Practitioners should under-
tand that adding CT venography to CTA increases the
ensitivity for PE without reducing specificity (44).
Knowledge of the use of CT venography in the evaluation
f venous thrombosis involving the upper extremity veins
brachiocephalic and axillary veins) is important, especially
n cases of suspected venous thrombosis due to malignancies
Malignant Superior Vena Cava Syndrome) (45). Owing to
he superior discriminatory properties of CT for lung
arenchyma over MRI, CT venography in conjunction with
T of the chest is the diagnostic study of choice for this
ype of evaluation. The expert should be capable of identi-
ying venous contrast mixing artifacts commonly seen in
tandard renal CTA in relation to discerning renal vein
hrombosis. The limitations of CTA for identifying mes-
nteric venous thrombosis should be appreciated, and the
redicted locations of mesenteric and portal veins should be
ncluded in the expert’s knowledge base.
. OTHER
he previous list is not meant to be exhaustive. There may
e other organ-specific applications, such as arteriovenous
able 2. Cognitive Skills Required for Competence in Vascular
Knowledge
eneral Physics of CT and radiation gen
Scanning principles and scanni
Principles of intravenous iodina
Prevention, recognition, and tre
Principles of image post-proces
ascular anatomy Normal anatomy of the aorta, b
arteries
Normal anatomy of the SVC an
ascular pathology Congenital anomalies, aneurysm
pelvic and lower extremity, re
Thrombosis, compression, occlu
mesenteric veins
ymptoms and signs of disease
related to above vasular
pathology
T  computed tomography; IVC  inferior vena cava; SVC  superior vena cava.alformations, which are not specifically addressed. Tormal Training and Competence in Vascular CT
here are several potential pathways to achieve competence
n vascular CT, including formal fellowship pathways and
lternative pathways. The training achieved may allow a
ractitioner to either interpret or, depending on the exper-
ise achieved, interpret and teach others the competencies in
ascular CT. Cognitive skills required to demonstrate com-
etence in vascular CTA are summarized in Table 2. All
rainees will be required to demonstrate competence in the
heoretical principles of CT imaging using MDCT tech-
ology. Candidates should receive didactic lectures from a
ualified CT-trained physician and/or physicist on the basic
hysics of CT in general and of MDCT in particular. A
horough understanding of contrast injection methods,
dverse events and their treatments, and contrast kinetics in
atients will be required. In particular, knowledge is needed
n appropriate bolus timing approaches that may be different
or various vascular beds.
For those in cardiology fellowship training programs,
pecific training in vascular anatomy and physiology
hrough dedicated vascular medicine training within the
ellowship would be required. A thorough knowledge and
nderstanding of vascular anatomy is required. Knowledge
f characteristics of blood vessels in health and disease by
raditional angiographic imaging methods (X-ray contrast
ngiography) provide a conceptual framework for applica-
ion to CTA of the peripheral vessels. Basic concepts in
essel physiology are vital for an angiographer interpreting a
tenosis in any vascular bed and basic training should be part
f any formal training program.
. Formal Fellowship
ormal training in vascular CT may be undertaken as part
f cardiovascular fellowship (see the latest COCATS guide-
ines for cardiovascular computed tomography [CCT]) (1).
Cognitive Skills
n and exposure
des for noncontrast- and contrast-enhanced vascular imaging
ntrast administration for safe and optimal vascular imaging
t of adverse reactions to iodinated contrast
nd appropriate applications
cephalic, cerebrovascular, pelvic and lower extremity, renal, and mesenteric
cerebrovascular, pelvic, lower extremity, renal, and mesenteric veins
section, occlusion, and stenosis, of the aorta, brachiocephalic, cerebrovascular,
nd mesenteric arteries
n and of the SVC and IVC, cerebrovascular, pelvic, lower extremity, renal, andCT
eratio
ng mo
ted co
atmen
sing a
rachio
d IVC,
, dis
nal, a
sion ihe didactic training experience achieved should parallel
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ACCF/AHA Clinical Competence Statement: Vascular CT/MR September 11, 2007:1097–114hat described in the COCATS recommendations for Level
trainees. Trainees should actively participate in daily CT
tudy interpretation under the direction of a Level 2 or 3
preferred) CCT-qualified physician. For all studies in
hich other vascular imaging data are available, such infor-
ation should be correlated with CT data. This should
nclude at least 50 cases of vascular CT, for which the
rainee is present during the scan, ideally as the primary
perator and the primary interpreter.
. Alternative Pathways
otential alternative pathways include spending at least 4
eeks with a practitioner of vascular CT who has the prior
xperience to train such an individual (Table 3). For those
ndividuals who have achieved Level 2 or 3 training in
ardiac CT, there is no specific time requirement. With
ither pathway, at least 50 cases of vascular CT should be
erformed to demonstrate competence, ideally for which the
rainee is present during the scan and is the primary
perator/interpreter. These cases should include the variety
f cases as previously outlined. An additional 100 cases from
eaching files, case studies, CDs/DVDs, or continuing
edical education (CME) courses should also be reviewed.
aintaining Expertise in Vascular CT
s is true for many other procedures, a minimum number of
ases are necessary to ensure continued proficiency in quality
f care.
. Clinical Experience
aintenance of vascular CT expertise requires both ongo-
ng CME and regular performance and interpretation of
ascular CT examinations. Physicians should periodically
ttend postgraduate courses and workshops that focus on
ascular CT, especially those that emphasize new and
volving techniques and developments. In addition, physi-
ians should seek to compare the quality, completeness, and
esults of their own examinations with those presented at
cientific meetings and in professional publications. If com-
etence is assured primarily on the basis of continuing
xperience, a minimum of 50 examinations per year is
able 3. Alternative Pathways for Competence
Pathway
nitial experience* ● Level 2 or 3 CCT tra
OR
● 4 weeks of dedicat
● Level 2 or 3 CCT tra
OR
● 4 weeks of addition
CD/DVD training
inimum number of mentored exams ● Mentored interpret
dditional case reviews ● 100 cases of vascu
If one has obtained Level 2 or 3 competence in CCT, the time requirement is waived.
CCT  cardiovascular computed tomography; CME  continuing medical education; CT  coecommended in order to maintain the physician’s skills. recause a physician’s practice or location may preclude this
ethod, continued competency can also be assured through
onitoring and evaluation that indicates acceptable techni-
al success, accuracy of interpretation, and appropriateness
f evaluation.
. CME
hirty hours of category I CME over 3 years in CCT or
elated fields are required to maintain expertise in vascular
T regardless of pathway.
ascular MR
ognitive Knowledge Required for Competency
. Hardware and General Principles of MR
brief overview of the technical aspects of cardiovascular
agnetic resonance (CMR) as it applies to evaluation of
lood vessels is included to facilitate the understanding of
erms used in the subsequent sections of this report
nd is not intended to be comprehensive. The practitio-
er of vascular MR should comprehend the general
rinciples of MR. Hardware used in an MR scanner are
isted in Table 4.
The phenomenon of MR is restricted to atomic nuclei
ith unpaired spin such as hydrogen atoms (protons). In the
resence of an external magnetic field, the hydrogen nucleus
cts like a small magnet and aligns itself parallel to an
xternal field, precessing about its axis in a manner analo-
ous to a spinning top. The frequency of precession for
ydrogen is 42.58 MHz/T, which corresponds to 63 MHz
t a field strength of 1.5 T and 128 MHz at 3 T, and is in
he radiofrequency (RF) range. Hydrogen nuclei can be
xcited by radio waves only at this resonant frequency
Larmor Frequency), which has the effect of rotating the net
agnetization vector by an amount termed the “flip angle.”
fter this excitation, the net magnetization returns to its
ormer position (relaxation) during which energy is trans-
itted as a radio signal and can be detected by a receiver
oil. The return of the net magnetization vector to equilib-
Description
e with a qualified practitioner of vascular CT
uivalent experience through supervised time, CME, other courses, case studies,
f 50 cases of vascular CT, ideally covering a broad range of vascular beds
from teaching files, case studies, CDs/DVDs, CME courses
tomography.ined
ed tim
ined
al eq
ation o
lar CTium has 2 components. The vector component parallel to
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September 11, 2007:1097–114 ACCF/AHA Clinical Competence Statement: Vascular CT/MRhe main field relatively slowly returns to equilibrium by
nteracting with surrounding molecules; this is known as
T1 relaxation.” Recovery of the vector component trans-
erse to the field is more rapid and is termed “T2 relax-
tion.” The CMR images can be weighted to T1, T2, or
roton density in order to derive signal differences that are
ntrinsic to the tissue and help characterize the latter. In
rder to localize the signals coming from the body, gradient
agnetic fields of varying magnitude (phase-encoding
teps) are switched on and off at appropriate times required
o spatially encode MR signal. An MR pulse sequence is a
ombination of RF pulses and magnetic gradient field
lterations controlled by the scanning computer.
To speed up image acquisition, parallel imaging tech-
iques have been developed. These are based on an optimal
tilization of redundant information from multiple phased-
rray coils and allow a reduction in the time-consuming
hase-encoding steps required to spatially encode MR
ignal. High spatial resolution images can be acquired in a
arkedly shortened time (often by a factor of 2 to 4).
arallel imaging is a mainstay of modern MRA and is used
n conjunction with a variety of techniques including
ontrast-enhanced magnetic resonance angiography (CE-
RA), where it allows rapid imaging during peak arterial
ontrast opacification. Potential limitations include a reduc-
ion in the signal-to-noise ratio.
. Acquisition Techniques
nowledge of MRA techniques is essential to the practi-
ioner of MRA. This brief summary outlines the major
echniques that the diagnostician should understand. MRA
as evolved rapidly since its introduction more than 15 years
go. Initially, non–CE-MRA techniques found their way
nto clinical routine for imaging vascular morphology.
hese early approaches can in principle be divided into 2
ubgroups (i.e., “black blood” and “bright blood” sequences).
lthough black blood techniques based on signal voids
ithin vessels containing flowing spins can confirm vessel
atency, they remain of limited use in the assessment of
ascular morphology. They are currently gaining accep-
ance, however, for the evaluation of the vascular wall (46).
Bright blood MRA techniques are generally divided into
hose influenced by the effect of blood flow on signal (time
f flight, or TOF) and those based on the flow effect on
hase (phase contrast, or PC). Advantages of TOF include
able 4. CMR Hardware
CMR Hardware
agnet Superconducting magnet with homogenous magn
radient coils Within the bore of the magnet. Current-carrying co
(so that the magnetic field will be stronger in so
adiofrequency coils Single or multiple loops of electrical conductor (e.g
conductor or to detect a voltage induced in the
eceiver coils Measures MR signal at the resonance frequency s
MR  computed magnetic resonance; MR  magnetic resonance; T  Tesla.strong signal from blood and that it is completely eoninvasive (no contrast agents are needed). However,
cquisition times are relatively long, and spin dephasing in
reas of flow turbulence results in signal loss that may lead
o stenosis overestimation. PC angiography derives image
ontrast from the differences in the phases accumulated by
tationary and moving spins in a magnetic field gradient.
he amount of phase accumulated is directly proportional
o the flow velocity, allowing quantitative measurement of
ow velocities and the discrimination of flow direction. The
ow dependence and associated artifacts inherent to these
echniques have restricted their clinical use primarily to the
xtracranial and intracranial arterial system and the portal
enous system.
With the advent of high-performance gradient systems,
ewer MRA strategies have been developed for CE-MRA
sing gadolinium chelates (47). Intravenous gadolinium
helates are the most commonly employed contrast agents
n clinical practice. MRA is based on the combination of
apid 3D imaging and the T1-shortening effect of intrave-
ously infused paramagnetic contrast. These agents greatly
horten the T1 of blood resulting in very bright signal
ntensity in T1-weighted images. Data acquisition needs to
e precisely timed to the arterial phase of the contrast when
ntraluminal signal is maximal, and be fast enough to
inimize motion artifacts and to avoid venous contamina-
ion that may hamper image interpretation. Advantages of
E-MRA over older TOF techniques include higher
ignal-to-noise ratios, robustness irrespective of blood flow
atterns or velocities, and faster image acquisition, allowing
or the evaluation of larger anatomic segments (from the
ortic arch to the circle of Willis). As variants of CE-MRA,
ime-resolved techniques enable the dynamic visualization
f contrast transit through the vasculature and are not
ependent on the precise timing of the acquisition, although
t the cost of lower spatial resolution. These techniques have
een proven to give an extensive and diagnostically accurate
valuation of extracranial, thoracic, abdominal, and periph-
ral vessels. In many centers, 3D CE-MRA has widely
eplaced conventional X-ray angiography for the clarifica-
ion of pathologies in arterial vessels (48).
. Image Processing and Interpretation
he practitioner of MRA should be knowledgeable about
ost-processing techniques that are performed at the com-
uter workstation console. Post-processing should include
Details
ld (1.5 T or 3.0 T)
h generates a highly linear magnetic field gradient along a particular direction
cations than others). Helps produce images.
, tubing) designed to produce a magnetic field from current flowing in the
ctor by a changing magnetic field.
the MR image can be produced.etic fie
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me lo
., wire
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ACCF/AHA Clinical Competence Statement: Vascular CT/MR September 11, 2007:1097–114eformatted images, such as MPR. Image subtraction may
e performed and MIPs using thick and/or thin slabs
ncompassing each vascular territory of interest may be
iewed for the purposes of diagnosis. Interpreters should
omprehend post-processing of PC images to calculate
ows in various vascular beds. Practitioners should be aware
f artifacts, such as pseudostenoses, created by metallic
evices (e.g., stents and clips).
. MRA Contrast
RA is usually performed with 3D coverage of the vessel
uring a short breath-hold and after intravenous injection of
gadolinium-based contrast agent. Gadolinium has 7 un-
aired electrons in its outer shell and hastens T1 relaxation,
hereby increasing signal in the area of interest. Gadolinium
lone is cytotoxic, but not when combined with a chelating
gent. Gadolinium has similar pharmacokinetic properties
o iodinated X-ray contrast but with minimal nephrotoxicity
nd anaphylaxis risk. Several Food and Drug Administra-
ion (FDA)-approved gadolinium preparations have been
sed for over a decade and the safety profile is far more
avorable than iodinated contrast. A study of high-dose
adolinium in a population with a high prevalence of
aseline renal insufficiency showed no renal failure associ-
ted with its administration (49). The rate of allergic
eactions to gadolinium is also very low. A survey of 105
enters with more than 700,000 patients receiving the
ontrast agent has been performed (50). The rate of adverse
eactions was very low and was limited to mild nausea,
omiting, and urticaria. The rate of serious allergic reactions
as less than 0.01% (50).
On May 23, 2007, the FDA updated a previously issued
ublic health advisory (51) after receiving 90 reports of
atients with at least moderate renal dysfunction, gadolin-
um exposure, and subsequent development of nephrogenic
ystemic fibrosis (NSF), a dermatologic condition that is
haracterized by severe and progressive skin induration (52).
he proposed association between gadolinium and NSF is
trengthened by recent reports of gadolinium isolated from
iopsy specimens up to 11 months post-administration in
atients with NSF (53). The updated FDA advisory states
hat exposure to gadolinium-based contrast agents increases
he risk for NSF in patients with acute or chronic severe
enal insufficiency (glomerular filtration rate less than 30
L/min/1.73 m2) or acute renal insufficiency of any severity
ue to the hepato-renal syndrome or in the perioperative
iver transplantation period. The risk, if any, for developing
SF among patients with mild to moderate renal insuffi-
iency or normal renal function is unknown. When recom-
ending or performing an MRI or MRA, carefully weigh
he benefits and risks associated with using a gadolinium-
ased contrast agent in light of recent reports of NSF/
ephrogenic fibrosing dermopahy observed following ad-
inistration of these agents. Choose an alternative imaging
ethod and/or contrast agent whenever possible. 2) Al-hough there are no published data to determine the utility mf dialysis to prevent or treat NSF/nephrogenic fibrosing
ermopahy, consider prompt dialysis of patients with mod-
rate to end-stage renal disease who undergo an MRI or
RA with a gadolinium-based contrast agent.
. MRI Safety
RI is very safe with no short- or long-term ill effects at
urrent field strengths (less than or equal to 3 T). Claus-
rophobia is problematic in 3% to 7% of patients. A very
mportant safety issue for CMR is the prevention of
erromagnetic objects from entering the scanner area as
hese will become projectiles. Metallic implants such as hip
rostheses, mechanical heart valves, coronary stents, and
ternal sutures present no hazard since the materials used are
ot ferromagnetic (although a local image artifact will
esult). Care is required in patients with cerebrovascular
lips as certain older models remain unsafe in the MR
nvironment. Electronic implants (i.e., infusion or monitor-
ng devices, neurostimulation devices) are still considered
bsolute contraindications. Pacemakers and implanted
ardioverter-defibrillators are considered a contraindication,
lthough recently there have been several case series of
atients with pacemakers who successfully underwent MR
canning at 1.5 T with very few changes in pacer function
54–56). This is an area of active investigation and MR-
ompatible devices are in development.
. Specific Applications
. AORTA
n understanding of the utility of MRA in diseases of the
orta is essential. MRA is an excellent technique to define
he overall size, shape, and extent of aortic aneurysms. MRI
as excellent sensitivity and specificity for the determination
f a presence of dissection, and it can cover large fields of
iew, permitting full assessment of its extent (57,58). It
hould be recognized that MRI offers certain advantages in
ortic dissection, including the ability to characterize
hrombus or slow flow in the false lumen by exploiting
ifferences in signal properties. Multiplanar noncontrast
maging can also help delineate intramural hematoma.
ractitioners of MRA should know how to use MRI and
RA to demonstrate the characteristic features of pene-
rating atherosclerotic ulcers (59). MRA of aortic coarcta-
ion requires the ability to recognize the site of narrowing,
nvolvement of branch vessels, and the extent of collateral
essels (60). Diagnosticians should understand the use of
C MRI techniques to measure the velocities and flow
roximal and distal to the narrowed segments, and estimate
he degree of stenosis and the amount of collateral flow (61).
. UPPER EXTREMITY ARTERIES
linical competence in MRA requires an understanding of
ts use in the assessment of abnormalities of the brachioce-
halic, subclavian, and axillary arteries. Interpreters of MRA
hould understand that atherosclerosis is the cause of the
ajority of stenotic and aneurysmal disease in the arteries of
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September 11, 2007:1097–114 ACCF/AHA Clinical Competence Statement: Vascular CT/MRhe upper extremities (62) and that MRA is quite accurate
n its diagnostic capacity in this regard (63). Practitioners of
RA should recognize “subclavian steal syndrome” and the
bility to depict reversal of flow by PC MRA or TOF MRA
ith a presaturation pulse first above and then below the
ertebral artery (64) as well as the use of CE-MRA to depict
he precise site of anatomic obstruction (65). A knowledge
f the use of multiple MR techniques in the evaluation of
nflammatory arteritis (66) is essential (e.g., Takayasu’s
rteritis which has a predeliction for involvement of the
ortic arch vessels). MRA can demonstrate evidence of giant
ell arteritis that can lead to stenoses or aneurysmal dilation
n the thoracic aorta and subclavian and axillary arteries.
R can be useful in the diagnosis of thoracic outlet
yndrome as MRI during arm abduction and adduction may
onfirm vascular compression (67). A competent interpreter
f MR of the arterial branches of the aortic arch should be
ble to recognize and evaluate congenital anomalies such as
vascular ring may cause tracheal or esophageal compres-
ion. MRA is an excellent test for evaluation of the arch.
iagnosticians should be familiar with volumetric interpo-
ated breath-hold examination imaging (68) after gadolin-
um, which can clearly demonstrate the relationship of the
rachea, esophagus, and arch vessels.
. EXTRACRANIAL CEREBROVASCULAR ARTERIES
nowledge of the signs and symptoms of cerebrovascular
isease, common syndromes attributable to specific arterial
egments and pathophysiology of stroke are essential ele-
ents to the interpretation of MRA. A thorough under-
tanding of cerebrovascular MRA is crucial as it has become
n integral part of the routine evaluation for cerebral
schemia. As MRI is used frequently in stroke, MRA can be
ncluded with only a few minutes of added scan time. The
ntracranial carotid artery is easily demonstrated with MRA,
nd gadolinium-enhanced MRA allows imaging of the
ntire circulation from the aortic arch to the first division of
he major intracranial arteries. 3D reconstructions result in an
xcellent view of eccentric or highly focal lesions that are not
lways apparent on the usual anteroposterior and lateral views.
Interpretation of MRA requires a detailed knowledge of
he anatomy of the cerebral circulation as well as an
nderstanding of the strengths and weaknesses of vascular
maging with MR in order to interpret normal and abnor-
al findings. A number of artifacts occur with MRA, and
hysicians involved in interpretation must understand these
itfalls. Due to the dephasing effects of turbulence, MRA
ay overestimate the severity of stenosis. MRA is highly
pecific but identification of significant stenoses generally
equires confirmation by another technique. Horizontal
egments of the carotid artery, such as the intracranial
egment, are less well visualized because of dephasing in the
orizontal plane and, thus, a diagnosis of stenosis in this
lane is not always reliable. The addition of cerebral MR
erfusion contributes complementary information and to- iether with MRA can improve understanding of the clinical
ignificance of arterial lesions.
Physicians interpreting MRA should know that its accu-
acy is similar to that of CTA for detecting intracranial
erebral aneurysms (69). Sensitivity is greater for larger
neurysms and falls precipitously for aneurysms less than 5
m. Physicians interpreting MRA should be aware of the
ifficulty detecting small aneurysms as well as common sites
f infundibulums and branch points that can be confused
ith aneurysms. Pitfalls of MRA, including the effects of
ovement, turbulence, and slow flow, should be considered.
nowledge of the common sites of aneurysms is important
or optimal recognition. Physicians should be well-versed in
he use of T1- and T2-weighted and fat-suppressed MRI as
ell as MRA to detect carotid dissection. It should be
ecognized that vertebral dissection is not as reliably iden-
ified. Knowledge of the use of MRA to detect arterial
njury, particularly dissection, is critical in the evaluation of
atients with trauma.
. PELVIC AND LOWER LIMB ARTERIES
thorough knowledge of techniques employed in periph-
ral MRA is essential. CE-MRA using a multistation
olus-chase technique in conjunction with dedicated pe-
ipheral phased-array coils and extended field of view
maging (500 mm) allow scanning from the diaphragm to
he pedal vessels in 3 stations. The addition of parallel
maging technologies, along with novel k-space reordering
chemes, especially in the distal stations, has made periph-
ral runoff MRA significantly more robust, with fewer failed
tudies and with vastly improved image quality (submilli-
eter isotropic voxels at the distal stations) (70). Diagnos-
icians should be cognizant of techniques to reduce venous
ontamination in the distal stations by the use of centric
-spaced ordered schemes for data acquisition in the distal
tations, along with biphasic administration of gadolinium,
ith a reduced rate of injection for the second bolus (48).
he use of venous compression devices at the level of the
highs (with pressures set to less than or equal to 50 mm
g) also has been shown to delay venous filling (71). The
dditional incorporation of a time resolved MRA or a
edicated 3D data set at the level of the calf, typically
erformed prior to a traditional multi-station 3D MRA
cquisition, has been shown to result in images devoid of
enous contamination and of excellent diagnostic quality
72,73). Physicians should recognize the high sensitivity and
pecificity of MRA for the diagnosis of PAD (74) and the
tility of MRA for assessing graft patency, as well as inflow
nd outflow disease (75).
Practitioners of vascular MR should understand the use
f additional vessel wall-specific sequences used in conjunc-
ion with MRA, particularly in the abdomen, which may
elp delineate aneurysms, presence of intramural clot, dis-
ection, and atherosclerosis with only a minimal increase in
can time. Sequences that may be chosen for this purpose
nclude dark-blood half Fourier acquisition single-shot
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nt echo sequence, or a traditional inversion recovery
repared gradient echo sequence, especially after contrast.
. RENAL ARTERIES
ractitioners of MR should appreciate that renal artery
tenosis is an important cause of secondary hypertension.
he knowledge required to perform renal MRA includes an
nderstanding of its ability to evaluate the renal arteries and
ccessory renal arteries directly (76), establish the site and
everity of stenoses, and their hemodynamic significance
77), measure kidney size and parenchymal thickness, and
dentify perirenal and aortic pathology. The specialist
hould be able to recognize and identify the causes of renal
rtery stenosis, which include atherosclerotic disease, fibro-
uscular dysplasia, arterial dissection, and extrinsic com-
ression of renal arteries. Aneurysms involving the main
enal arteries should be identified; however, the smaller
ntraparenchymal aneurysms seen in polyarteritis nodosa
ay not be as reliably detected. Physicians should compre-
end the pulse sequences used to assess the renal arteries
ncluding 2D or 3D TOF, PC imaging, and CE-MRA.
he use of contrast allows for a more accurate evaluation of
ortuous vessels, distal vessels, and smaller accessory renal
rteries and can aid in the diagnosis of fibromuscular
ysplasia. The MRA interpreters should have knowledge of
he use of the technique in renal donors or after renal
ransplantation. The expert should be able to use post-
rocessing techniques including subvolume MIPs encom-
assing each renal artery in coronal, oblique, and axial
lanes (78).
. MESENTERIC ARTERIES
hysicians should recognize that unlike acute mesenteric
schemia, chronic mesenteric ischemia due to atherosclerotic
isease is well-suited for evaluation by MRA. Knowledge of
he appropriate pulse sequence to use for this disorder is
ssential. Although TOF (79) and PC MRA (80) can be
sed, CE-MRA is more robust and faster, especially when
arallel imaging techniques are applied (47,81). The CE-
RA techniques are highly accurate and compare favorably
o catheter-based approaches (82). The specialist should
lso be able to recognize normal anatomy and its variations
s well as surgical anatomy. The causes of acute and chronic
esenteric ischemia need to be recognized and specific
tiologies such as atherosclerosis, arterial and venous throm-
osis, external compression, and vasculitis should be iden-
ified. The specialist should also be able to identify pseudo-
tenosis and aneurysmal disease. Practitioners of MRA
hould be able to recognize anatomic variations and celiac
rtery pseudostenosis, which is commonly caused by extrin-
ic compression by the median arcuate ligament. MRA can
lso be useful for evaluation after a revascularization proce-
ure and for examining the extent and nature of external
ompression on mesenteric arteries or veins. s. MR VENOGRAPHY
nowledge of superior vena cava (SVC) and IVC anatomy,
s well as potential causes of compression or obstruction
tumor, thrombus, etc.), is essential to the interpreter of
RA (83). It is important to recognize benign systemic
enous anomalies such as a persistent left SVC with or
ithout azygous continuation of the IVC (84). In the
erebral circulation, knowledge of typical clinical syndromes
f venous infarction and the imaging characteristics of
enous infarcts that distinguish them from arterial disease is
ssential to proper interpretation. MR venography visualizes
he major venous sinuses and detailed knowledge of venous
natomy is necessary to identify occlusive disease associated
ith infarction. Physicians should have knowledge of com-
on congenital variants that might be misinterpreted as a
athological venous occlusion. They should understand that
esenteric venous occlusion is an uncommon but important
ause of mesenteric ischemia. Practitioners of MRA should
nderstand the potential of multiphase dynamic CE imag-
ng (85) for examination of the venous system.
. WHOLE BODY MRA
here is a known relationship between the presence of
ignificant stenoses in one vascular bed with asymptomatic
isease in another (86). Thus, practitioners of MRA should
ppreciate whole body MRA as a potential screening tool.
his has been performed by combining the bolus-chase
pproach with a rolling table platform (87). Knowledge of
echniques to optimize whole body MRA is important
ncluding the use of integrated parallel acquisition tech-
iques to increase spatial and temporal resolution and
educe venous contamination in the abdomen and infrap-
pliteal region, without an increase in acquisition time (88).
owever, the clinical value of whole body MRA has not yet
een systematically tested in large populations.
ormal Training to Achieve Competence
ognitive skills required to demonstrate competence in
ascular MR are summarized in Table 5. The physician
hould be able to demonstrate competence in the theoretical
rinciples of MRI. Trainees should receive didactic lectures
rom a qualified MR-trained physician and/or physicist on
he basic physics of MR. A thorough understanding of
ontrast injection methods and contrast kinetics in patients
ill be required. In particular, knowledge is needed in
ppropriate bolus timing approaches that may be different
or various vascular beds. A thorough knowledge and
nderstanding of vascular anatomy is required. Character-
stics of a vessel in health and disease by traditional
ngiographic imaging methods (X-ray contrast angiogra-
hy) will provide a significant background for application to
RA of the peripheral vessels. An understanding of basic
oncepts in vessel physiology is vital for an angiographer
nterpreting a stenosis in any vascular bed and basic training
hould be part of any formal training program.
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September 11, 2007:1097–114 ACCF/AHA Clinical Competence Statement: Vascular CT/MRThere are several potential pathways to achieve compe-
ence in vascular MR including formal fellowships and
lternative pathways, both with accompanying CME. The
raining achieved may allow a practitioner to either interpret
r, depending on the expertise achieved, interpret and teach
thers the competencies in vascular MR. Table 5 lists the
ognitive skills required for competence in vascular MR.
. Formal Fellowship
ormal training in vascular MR may be undertaken as part
f cardiovascular fellowship (see the latest COCATS guide-
ines for CMR) (1). The didactic training experience
chieved should parallel that described in the COCATS
uidelines for Level 2 trainees. A basic understanding of
R physics and clinical applications should be obtained.
rainees should actively participate in daily MR study
nterpretation under the direction of a Level 2 or 3 (pre-
erred) CMR-qualified physician. For all studies in which
ther vascular imaging data are available, such information
hould be correlated with MR data. This should include at
east 50 cases of vascular MR, for which the trainee is
resent during the scan, ideally as the primary operator and
he primary interpreter.
able 5. Cognitive Skills Required for Competence in Vascular
Knowledge
eneral Hardware and physical principle
Scanning principles and scannin
Principles of intravenous contra
Principles of image post-proces
Safety issues surrounding MR, i
ascular anatomy Normal anatomy of the aorta, b
arteries
Normal anatomy of the SVC an
ascular pathology Congenital anomalies, aneurysm
pelvic and lower extremity, re
Thrombosis, compression, and
extremity, renal, and mesent
ymptoms and signs of disease
related to the vascular
pathology listed above
VC  inferior vena cava; MR  magnetic resonance; SVC  superior vena cava.
able 6. Alternative Pathways for Competence in Vascular MR
Pathway
nitial experience* ● Level 2 or 3 CMR t
OR
● 4 weeks of dedicat
● Level 2 or 3 CMR t
OR
● 4 weeks of addition
CD/DVD training
inimum number of mentored exams ● Mentored interpret
dditional case reviews ● 100 cases from teaIf one has obtained Level 2 or 3 competence in CMR, the time requirement is waived.
CME  continuing medical education; CMR  cardiovascular magnetic resonance; CT  computed t. Alternative Pathways
lternative pathways (Table 6) include at least 4 weeks
pent with a practitioner of vascular MR who has the prior
raining experience. For those individuals who have
chieved Level 2 or 3 training in CMR, there is no specific
ime requirement. With either pathway, at least 50 cases of
ascular MR should be performed to demonstrate compe-
ence, ideally for which the trainee is present during the scan
nd is the primary operator/interpreter. These cases should
nclude the variety of cases as previously outlined. An
dditional 100 cases from teaching files, case studies, CDs/
VDs, or CME courses also should be reviewed.
aintaining Expertise
s is true for many other procedures, a minimum number of
ases are necessary to ensure continued proficiency in quality
f care.
. Clinical Experience
aintenance of vascular MR expertise requires both ongo-
ng CME and regular performance and interpretation of
ascular MR examinations. Physicians should periodically
Cognitive Skills Required
R
des for noncontrast- and contrast-enhanced vascular imaging
inistration for optimal vascular imaging
nd appropriate applications
ng contraindications
cephalic, cerebrovascular, pelvic and lower extremity, renal, and mesenteric
cerebrovascular, pelvic, lower extremity, renal, and mesenteric veins
ection, occlusion, and stenosis) of the aorta, brachiocephalic, cerebrovascular,
nd mesenteric arteries
ion of the superior and inferior vena cava, cerebrovascular, pelvic, lower
ins
Description
e with a qualified practitioner of vascular MR
uivalent experience through supervised time, CME, other courses, case studies,
f 50 cases of vascular MR, ideally covering a broad range of vascular beds
files, case studies, CDs/DVDs, CME coursesMR
s of M
g mo
st adm
sing a
ncludi
rachio
d IVC,
, diss
nal, a
occlus
eric verained
ed tim
rained
al eq
ation o
chingomography; MR  magnetic resonance.
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ACCF/AHA Clinical Competence Statement: Vascular CT/MR September 11, 2007:1097–114ttend postgraduate courses and workshops that focus on
ascular MR, especially those that emphasize new and
volving techniques and developments. In addition, physi-
ians should seek to compare the quality, completeness, and
esults of their own examinations with those presented at
cientific meetings and in professional publications. If com-
etence is assured primarily on the basis of continuing
xperience, a minimum of 50 examinations per year is
ecommended in order to maintain the physician’s skills.
ecause a physician’s practice or location may preclude this
ethod, continued competency can also be assured through
onitoring and evaluation that indicates acceptable techni-
al success, accuracy of interpretation, and appropriateness
f evaluation.
. CME
hirty hours of CME over 3 years in CMR or related fields
re required to maintain expertise in vascular MR.
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